Over Top 3 weight loss product
REtatrutide (8MG)
Weight loss
Status: Not FDA-approved yet (as of mid-2025) — in late-stage trials
Class: Triple Agonist — GLP-1, GIP, and Glucagon receptor agonist
Dosage: Studied in doses from 1 mg to 12 mg+ weekly
Administration: Subcutaneous injection, once weekly.
$25.00
Semaglutide (GLP-1)
Weight loss
Brand Names: Ozempic®, Wegovy®, Rybelsus®
Class: GLP-1 Receptor Agonist
Dosage: Typically 0.25 mg to 2.4 mg once weekly (Wegovy), or up to 2.0 mg (Ozempic for diabetes)
Administration: Subcutaneous injection, once weekly
$25.00
Tirzepatide (Tirz)
Weight loss
Brand Name: Mounjaro®
Class: Dual GIP and GLP-1 Receptor Agonist
Dosage: 2.5 mg to 15 mg once weekly
Administration: Subcutaneous injection, once weekly
